Literature DB >> 26442472

Structural phase transitions and photoluminescence properties of Eu(3+) doped Ca(2-x)BaxLaNbO6 phosphors.

Jicheng Zhu1, Zhiguo Xia, Yuanyuan Zhang, Maxim S Molokeev, Quanlin Liu.   

Abstract

Crystal structures of the series of double perovskites Ca(2-x)BaxLaNbO6:Eu(3+) phosphors have been examined by powder X-ray diffraction and Rietveld refinements. Ca2LaNbO6 has a monoclinic (P21/n) and Ba2LaNbO6 has a monoclinic (C2/m) structure. The structural phases of Ca(2-x)BaxLaNbO6:Eu(3+) samples are divided into three sections depending on different Ca/Ba ratios: (1) monoclinic phase (P21/n) as Ca2LaNbO6 in the range of x = 0-0.1, (2) mixed phases containing Ca2LaNbO6 and Ba2LaNbO6 between 0.15 and 1.2, and (3) monoclinic phase (C2/m) as Ba2LaNbO6 for x = 1.4-2. Eu(3+) ions act as the structural probes to study the structural phase transitions, and the evolution of the photoluminescence properties and thermal stability behaviours has been also comparatively investigated depending on different structural symmetries from Ca2LaNbO6 to Ba2LaNbO6 phase. The strong red emission from (5)D0-(7)F2 peaking at 618 nm can be found in Ca2LaNbO6:Eu(3+) phosphors, which is attributed to the low crystal field effect of the activator ions located in the highly distorted [LaO8] polyhedra sites. The composition-optimized phosphors can find applications in white light emitting diodes (LEDs).

Entities:  

Year:  2015        PMID: 26442472     DOI: 10.1039/c5dt03430b

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Photoluminescence properties of novel Ba2Lu5B5O17:Eu3+ red emitting phosphors with high color purity for near-UV excited white light emitting diodes.

Authors:  G Annadurai; Balaji Devakumar; Heng Guo; Bin Li; Liangling Sun; Xiaoyong Huang
Journal:  RSC Adv       Date:  2018-08-28       Impact factor: 4.036

2.  Highly efficient red-emitting Ca2YSbO6:Eu3+ double perovskite phosphors for warm WLEDs.

Authors:  Meijiao Liu; Biao Shen; Keyuan Wang; Jiasong Zhong; Daqin Chen
Journal:  RSC Adv       Date:  2019-07-03       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.